OZANIMOD EFFICACY BY BASELINE ENDOSCOPIC DISEASE DISTRIBUTION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: A POST HOC ANALYSIS FROM TRUE NORTH

Axel Dignass  ¹     Anita Afzali  ²     Monika Fischer  ³     Charles Sninsky  ⁴     Alessandro Armuzzi  ⁵     Chun Wu  ⁶     HARRIS AHMAD  ⁶     Arteid Memaj  ⁶     Sarah Harris  ⁶     James Canavan  ⁶     Stefan Schreiber  ^7    
1 Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany
² The Ohio State University Wexner Medical Center, Columbus, United States
³ Indiana University, Indianapolis, United States
⁴ Digestive Disease Associates, Gainesville, United States
⁵ RCCS Humanitas Research Hospital Humanitas University, Milan, Italy
⁶ Bristol Myers Squibb, Princeton, United States
⁷ Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)